Biomarker ID | 1265 |
PMID | 24358122 |
Year | 2013 |
Biomarker | E-Cadherin |
Biomarker Basis | Expression Based |
Biomolecule | mRNA |
Source | Cell Lines |
Subjects | Humans |
Regulation | Downregulated in: [CAHPV-10 (2.3 fold) ; DU145 (5.6 fold); PC-3 (7.25 fold)] |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | NA |
Experiment | CAHPV-10, DU145, PC-3, LNCaP Vs PNT2 |
Type of Biomarker | Diagnostic |
Cohort | Cell lines derived from normal prostate epithelial tissue (PNT2), non-invasive (CAHPV-10) and invasive prostate cancer (LNCaP, DU145, PC-3) were taken for this study |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | CAHPV-10 (p= 0.004); DU145 (p<0.001); PC-3 (p<0.001); |
Method Used | qRT-PCR |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on human patient cohort |
Technical Name | NA |